X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Cipla - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs CIPLA - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD CIPLA WYETH LTD/
CIPLA
 
P/E (TTM) x 27.7 44.4 62.4% View Chart
P/BV x 5.3 3.9 137.9% View Chart
Dividend Yield % 1.3 0.3 384.8%  

Financials

 WYETH LTD   CIPLA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
CIPLA
Mar-17
WYETH LTD/
CIPLA
5-Yr Chart
Click to enlarge
High Rs1,044622 167.9%   
Low Rs818458 178.5%   
Sales per share (Unadj.) Rs298.6181.9 164.2%  
Earnings per share (Unadj.) Rs57.212.9 444.8%  
Cash flow per share (Unadj.) Rs58.429.3 199.3%  
Dividends per share (Unadj.) Rs17.002.00 850.0%  
Dividend yield (eoy) %1.80.4 493.0%  
Book value per share (Unadj.) Rs249.5155.7 160.2%  
Shares outstanding (eoy) m22.72804.51 2.8%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.13.0 105.0%   
Avg P/E ratio x16.342.0 38.8%  
P/CF ratio (eoy) x15.918.4 86.5%  
Price / Book Value ratio x3.73.5 107.6%  
Dividend payout %29.715.5 191.1%   
Avg Mkt Cap Rs m21,157434,516 4.9%   
No. of employees `0000.523.0 2.1%   
Total wages/salary Rs m40026,338 1.5%   
Avg. sales/employee Rs Th13,787.46,349.1 217.2%   
Avg. wages/employee Rs Th813.01,143.0 71.1%   
Avg. net profit/employee Rs Th2,643.3449.3 588.3%   
INCOME DATA
Net Sales Rs m6,783146,302 4.6%  
Other income Rs m3532,287 15.4%   
Total revenues Rs m7,136148,589 4.8%   
Gross profit Rs m1,61724,758 6.5%  
Depreciation Rs m2713,229 0.2%   
Interest Rs m61,594 0.3%   
Profit before tax Rs m1,93812,222 15.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-70 0.0%   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6321,798 35.2%   
Profit after tax Rs m1,30110,354 12.6%  
Gross profit margin %23.816.9 140.9%  
Effective tax rate %32.614.7 221.8%   
Net profit margin %19.27.1 270.9%  
BALANCE SHEET DATA
Current assets Rs m6,98487,370 8.0%   
Current liabilities Rs m2,05633,081 6.2%   
Net working cap to sales %72.637.1 195.8%  
Current ratio x3.42.6 128.6%  
Inventory Days Days9987 114.1%  
Debtors Days Days2462 38.4%  
Net fixed assets Rs m244111,567 0.2%   
Share capital Rs m2271,609 14.1%   
"Free" reserves Rs m5,441123,645 4.4%   
Net worth Rs m5,668125,254 4.5%   
Long term debt Rs m2536,454 0.1%   
Total assets Rs m7,901209,532 3.8%  
Interest coverage x353.38.7 4,076.1%   
Debt to equity ratio x00.3 1.5%  
Sales to assets ratio x0.90.7 123.0%   
Return on assets %16.55.7 289.9%  
Return on equity %22.98.3 277.6%  
Return on capital %34.08.5 400.5%  
Exports to sales %0.234.2 0.6%   
Imports to sales %36.38.3 435.7%   
Exports (fob) Rs m1550,050 0.0%   
Imports (cif) Rs m2,46512,203 20.2%   
Fx inflow Rs m1551,066 0.0%   
Fx outflow Rs m2,67717,678 15.1%   
Net fx Rs m-2,66233,388 -8.0%   
CASH FLOW
From Operations Rs m92323,824 3.9%  
From Investments Rs m317-13,127 -2.4%  
From Financial Activity Rs m-481-13,239 3.6%  
Net Cashflow Rs m759-2,478 -30.6%  

Share Holding

Indian Promoters % 0.0 16.0 -  
Foreign collaborators % 51.1 20.8 245.7%  
Indian inst/Mut Fund % 11.3 12.2 92.6%  
FIIs % 7.2 23.7 30.4%  
ADR/GDR % 0.0 1.1 -  
Free float % 30.4 26.2 116.0%  
Shareholders   21,978 161,166 13.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare WYETH LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Flat; Realty Sector Down 2.1%(11:30 am)

Stock markets in India are presently trading on a flattish note. Sectoral indices are trading on a mixed note with stocks in the realty sector and metal sector witnessing maximum selling pressure.

Related Views on News

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Cipla: Extraordinary Income Boosts Net Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

Proceeds from the sale of the South African animal business bolstered Cipla's net profits for the quarter.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD 8-QTR ANALYSIS

COMPARE WYETH LTD WITH

MARKET STATS